Nodal Metastases in Thyroid Cancer: Prognostic Implications and Management

References

• Crile GJ . The pattern of metastasis of carcinoma of the thyroid. Ann. Surg.143(5), 580–587 (1956).
   PubMed Web of Science ®Google Scholar
• Shaha AR , LoreeTR, ShahJP. Intermediate-risk group for differentiated carcinoma of thyroid. Surgery116(6), 1036–1040; discussion 1040–1031 (1994).
   PubMed Web of Science ®Google Scholar
• Hay ID , BergstralhEJ, GoellnerJR, EbersoldJR, GrantCS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery114(6), 1050–1057; discussion 1057–1058 (1993).
   PubMed Web of Science ®Google Scholar
• Cady B , RossiR. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery104(6), 947–953 (1988).
   PubMed Web of Science ®Google Scholar
• Sugitani I , KasaiN, FujimotoY, YanagisawaA. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery135(2), 139–148 (2004).
   PubMed Web of Science ®Google Scholar
• Ito Y , FukushimaM, TomodaCet al. Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment. Endocr. J.56(6), 759–766 (2009).
   PubMed Web of Science ®Google Scholar
• Wang L , PalmerF, NixonIet al. Central lymph node characteristics predictive of outcome in patients with differentiated thyroid cancer. Thyroid30(12), 30 (2014).
   Google Scholar
• Wang LY , PalmerFL, MigliacciJCet al. Role of RAI in the management of incidental N1a disease in papillary thyroid cancer. Clin. Endocrinol. (Oxf.) doi: 10.1111/cen.12828 (2015) ( Epub ahead of print).
   Google Scholar
• Wang LY , PalmerFL, NixonIJet al. Lateral neck lymph node characteristics prognostic of outcome in patients with clinically evident N1b papillary thyroid cancer. Ann. Surg. Oncol.22(11), 3530–3536 (2015).
   PubMed Web of Science ®Google Scholar
• Goropoulos A , KaramoshosK, ChristodoulouAet al. Value of the cervical compartments in the surgical treatment of papillary thyroid carcinoma. [Erratum appears in World J. Surg. 30 (1), 140 (2006)]. World J. Surg.28(12), 1275–1281 (2004).
   PubMed Web of Science ®Google Scholar
• Gimm O , RathFW, DralleH. Pattern of lymph node metastases in papillary thyroid carcinoma. Br. J. Surg.85(2), 252–254 (1998).
   PubMed Web of Science ®Google Scholar
• Machens A , HinzeR, ThomuschO, DralleH. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J. Surg.26(1), 22–28 (2002).
   PubMed Web of Science ®Google Scholar
• Mirallie E , VissetJ, SaganC, HamyA, Le BodicMF, PaineauJ. Localization of cervical node metastasis of papillary thyroid carcinoma. World J. Surg.23(9), 970–973; discussion 973–974 (1999).
   PubMed Web of Science ®Google Scholar
• Machens A , HolzhausenH-J, DralleH. Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch. Surg.139(1), 43–45 (2004).
   PubMedGoogle Scholar
• Shaha AR , ShahJP, LoreeTR. Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann. Surg. Oncol.3(6), 534–538 (1996).
   PubMed Web of Science ®Google Scholar
• Blanchard C , BrientC, VolteauCet al. Factors predictive of lymph node metastasis in the follicular variant of papillary thyroid carcinoma. Br. J. Surg.100(10), 1312–1317 (2013).
   PubMed Web of Science ®Google Scholar
• Grebe SK , HayID. Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg. Oncol. Clin. N. Am.5(1), 43–63 (1996).
   PubMedGoogle Scholar
• Harwood J , ClarkOH, DunphyJE. Significance of lymph node metastasis in differentiated thyroid cancer. Am. J. Surg.136(1), 107–112 (1978).
   PubMed Web of Science ®Google Scholar
• Hughes CJ , ShahaAR, ShahJP, LoreeTR. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck18(2), 127–132 (1996).
   PubMed Web of Science ®Google Scholar
• Nixon I , WangL, PalmerFet al. The impact of nodal status on outcome in older patients with papillary thyroid cancer. Surgery156(1), 137–146 (2014).
   PubMed Web of Science ®Google Scholar
• Zaydfudim V , FeurerID, GriffinMR, PhayJE. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery144(6), 1070–1077; discussion 1077–1078 (2008).
   PubMed Web of Science ®Google Scholar
• Edge SB . American Joint Committee on Cancer. AJCC Cancer Staging Manual (7th Edition). Springer, New York, NY, USA (2010).
   Google Scholar
• Cooper DS , DohertyGM, HaugenBRet al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid19(11), 1167–1214 (2009).
   PubMed Web of Science ®Google Scholar
• Pitoia F , BuenoF, UrciuoliC, AbelleiraE, CrossG, TuttleRM. Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American Thyroid Association and Latin American thyroid society risk of recurrence classification systems. Thyroid23(11), 1401–1407 (2013).
   PubMed Web of Science ®Google Scholar
• Leboulleux S , RubinoC, BaudinEet al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J. Clin. Endocrinol. Metab.90(10), 5723–5729 (2005).
   PubMed Web of Science ®Google Scholar
• Ito Y , JikuzonoT, HigashiyamaTet al. Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J. Surg.30(10), 1821–1828 (2006).
   PubMed Web of Science ®Google Scholar
• Beal SH , ChenSL, SchneiderPD, MartinezSR. An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma. Am. Surg.76(1), 28–32 (2010).
   PubMed Web of Science ®Google Scholar
• Lee J , SongY, SohE. Prognostic significance of the number of metastatic lymph nodes to stratify the risk of recurrence. World J. Surg.4, 4 (2013).
   Google Scholar
• Jeon MJ , YoonJH, HanJMet al. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma. Eur. J. Endocrinol.168(2), 219–225 (2013).
   PubMed Web of Science ®Google Scholar
• Randolph G , DuhQ, HellerKet al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid22(11), 1144–1152 (2012).
   PubMed Web of Science ®Google Scholar
• Haugen BRM , AlexanderEK, BibleKCet al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid26(1), 1–133 (2016).
   PubMed Web of Science ®Google Scholar
• Perros P , BoelaertK, ColleySet al. British Thyroid Association guidelines for the management of thyroid cancer. Clin. Endocrinol. (Oxf.)81(Suppl. 1), 1–122 (2014).
   PubMed Web of Science ®Google Scholar
• Pacini F , SchlumbergerM, DralleH, EliseiR, SmitJW, WiersingaW. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur. J. Endocrinol.154(6), 787–803 (2006).
   PubMed Web of Science ®Google Scholar
• Pitoia F , WardL, WohllkNet al. Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer. Arq. Bras. Endocrinol. Metabol.53(7), 884–887 (2009).
   PubMedGoogle Scholar
• Takami H , ItoY, OkamotoT, YoshidaA. Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons. World J. Surg.35(1), 111–121 (2011).
   PubMed Web of Science ®Google Scholar
• Mazzaferri EL , JhiangSM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am. J. Med.97(5), 418–428 (1994).
   PubMed Web of Science ®Google Scholar
• Ito Y , TomodaC, UrunoTet al. Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J. Surg.29(7), 917–920 (2005).
   PubMed Web of Science ®Google Scholar
• Moore KH , ThalerHT, TanLK, BorgenPI, CodyHS3rd. Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biologic metastasis or procedural artifact?Cancer100(5), 929–934 (2004).
   PubMed Web of Science ®Google Scholar
• Cooper DS , DohertyGM, HaugenBRet al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid16(2), 109–142 (2006).
   PubMed Web of Science ®Google Scholar
• British Thyroid Association (2007) Guidelines for the management of thyroid cancer (2nd Edition). www.british-thyroid-association.org/news/Docs/Thyroid_cancer_guidelines_2007.pdf.
   Google Scholar
• Thyroid Carcinoma. Ver 2.2015. www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf.
   Google Scholar
• Sywak M , CornfordL, RoachP, StalbergP, SidhuS, DelbridgeL. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery140(6), 1000–1005; discussion 1005–1007 (2006).
   PubMed Web of Science ®Google Scholar
• Pereira JA , JimenoJ, MiquelJet al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery138(6), 1095–1100; discussion 1100–1091 (2005).
   PubMed Web of Science ®Google Scholar
• Rosenbaum MA , MchenryCR. Central neck dissection for papillary thyroid cancer. Arch. Otolaryngol. Head Neck Surg.135(11), 1092–1097 (2009).
   PubMedGoogle Scholar
• Lang BH , LeeGC, NgCP, WongKP, WanKY, LoCY. Evaluating the morbidity and efficacy of reoperative surgery in the central compartment for persistent/recurrent papillary thyroid carcinoma. World J. Surg.37(12), 2853–2859 (2013).
   PubMed Web of Science ®Google Scholar
• Moreno MA , Edeiken-MonroeBS, SiegelER, ShermanSI, ClaymanGL. In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival. Thyroid22(4), 347–355 (2012).
   PubMed Web of Science ®Google Scholar
• Hughes DT , WhiteML, MillerBS, GaugerPG, BurneyRE, DohertyGM. Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery148(6), 1100–1106; discussion 1006–1107 (2010).
   PubMed Web of Science ®Google Scholar
• Shindo M , WuJC, ParkEE, TanzellaF. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer. Arch. Otolaryngol. Head Neck Surg.132(6), 650–654 (2006).
   PubMedGoogle Scholar
• Nixon IJ , GanlyI, PatelSGet al. Observation of clinically negative central compartment lymph nodes in papillary thyroid carcinoma. Surgery154(6), 1166–1172; discussion 1172–1163 (2013).
   PubMed Web of Science ®Google Scholar
• Lang BH-H , WongKP, WanKY, LoC-Y. Significance of metastatic lymph node ratio on stimulated thyroglobulin levels in papillary thyroid carcinoma after prophylactic unilateral central neck dissection. Ann. Surg. Oncol.19(4), 1257–1263 (2012).
   PubMed Web of Science ®Google Scholar
• Ito Y , IchiharaK, MasuokaHet al. Establishment of an intraoperative staging system (iStage) by improving UICC TNM classification system for papillary thyroid carcinoma. World J. Surg.34(11), 2570–2580 (2010).
   PubMed Web of Science ®Google Scholar
• Yamashita H , NoguchiS, MurakamiN, KawamotoH, WatanabeS. Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma. Cancer.80(12), 2268–2272 (1997).
   PubMed Web of Science ®Google Scholar
• Carter R , BlissJ, SooK, O’BrienC. Radical neck dissections for squamous carcinomas: pathological findings and their clinical implications with particular reference to transcapsular spread. Int. J. Radiat. Oncol. Biol. Phys.13(6), 825–832 (1987).
   PubMed Web of Science ®Google Scholar
• Johnson JT , MyersEN, BedettiCD, BarnesEL, SchrammVJ, ThearlePB. Cervical lymph node metastases. Incidence and implications of extracapsular carcinoma. Arch. Otolaryngol.111(8), 534–537 (1985).
   PubMedGoogle Scholar
• Cooper J , PajakT, ForastiereAet al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N. Engl. J. Med.350(19), 1937–1944 (2004).
   PubMed Web of Science ®Google Scholar
• Spires J , RobbinsK, LunaM, ByersR. Metastatic papillary carcinoma of the thyroid: the significance of extranodal extension. Head Neck.11(3), 242–246 (1989).
   PubMed Web of Science ®Google Scholar
• Ricarte-Filho J , GanlyI, RiveraMet al. Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension. Thyroid22(6), 575–584 (2012).
   PubMed Web of Science ®Google Scholar
• Lango M , FliederD, ArrangoizRet al. Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression. Thyroid23(9), 1099–1105 (2013).
   PubMed Web of Science ®Google Scholar
• Ito Y , HirokawaM, JikuzonoTet al. Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma. World J. Surg.31(6), 1194–1201 (2007).
   PubMed Web of Science ®Google Scholar
• Marchet A , MocellinS, AmbrosiAet al. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann. Surg.245(4), 543–552 (2007).
   PubMed Web of Science ®Google Scholar
• Dekker J , PeetersK, PutterH, VahrmeijerA, Van De VeldeC. Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification. Eur. J. Surg. Oncol.36(12), 1180–1186 (2010).
   PubMed Web of Science ®Google Scholar
• Berger AC , WatsonJC, RossEA, HoffmanJP. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am. Surg.70(3), 235–240; discussion 240 (2004).
   PubMed Web of Science ®Google Scholar
• Woodward W , Vinh-HungV, UenoNet al. Prognostic value of nodal ratios in node-positive breast cancer. J. Clin. Oncol.24(18), 2910–2916 (2006).
   PubMed Web of Science ®Google Scholar
• Gil Z , CarlsonD, BoyleJet al. Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer115(24), 5700–5710 (2009).
   PubMed Web of Science ®Google Scholar
• Mizrachi A , HadarT, RabinovicsNet al. Prognostic significance of nodal ratio in cutaneous squamous cell carcinoma of the head and neck. Eur. Arch. Otorhinolaryngol.270(2), 647–653 (2013).
   PubMed Web of Science ®Google Scholar
• Howell GM , NikiforovaMN, CartySEet al. BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. Ann. Surg. Oncol.20(1), 47–52 (2013).
   PubMedGoogle Scholar
• Lang BH , ChaiYJ, CowlingBJ, MinHS, LeeKE, YounYK. Is BRAFV600E mutation a marker for central nodal metastasis in small papillary thyroid carcinoma?Endocr. Relat. Cancer21(2), 285–295 (2014).
   PubMed Web of Science ®Google Scholar
• Xing M , AlzahraniAS, CarsonKAet al. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer. J. Clin. Oncol.33(1), 42–50 (2015).
   PubMed Web of Science ®Google Scholar
• Basolo F , TorregrossaL, GianniniRet al. Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 cases. J. Clin. Endocrinol. Metab.95(9), 4197–4205 (2010).
   PubMed Web of Science ®Google Scholar
• Elisei R , ViolaD, TorregrossaLet al. The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study. J. Clin. Endocrinol. Metab.97(12), 4390–4398 (2012).
   PubMed Web of Science ®Google Scholar
• Kebebew E , WengJ, BauerJet al. The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann. Surg.246(3), 466–470; discussion 470–461 (2007).
   PubMed Web of Science ®Google Scholar
• Pak K , SuhS, KimSJ, KimIJ. Prognostic value of genetic mutations in thyroid cancer: a meta-analysis. Thyroid25(1), 63–70 (2015).
   PubMed Web of Science ®Google Scholar
• Tufano RP , BishopJ, WuG. Reoperative central compartment dissection for patients with recurrent/persistent papillary thyroid cancer: efficacy, safety, and the association of the BRAF mutation. Laryngoscope122(7), 1634–1640 (2012).
   PubMed Web of Science ®Google Scholar
• Xing M , HaugenBR, SchlumbergerM. Progress in molecular-based management of differentiated thyroid cancer. Lancet381(9871), 1058–1069 (2013).
   PubMed Web of Science ®Google Scholar
• Tufano RP , TeixeiraGV, BishopJ, CarsonKA, XingM. BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis. Medicine (Baltimore).91(5), 274–286 (2012).
   PubMed Web of Science ®Google Scholar
• Wang L , PalmerF, ThomasDet al. Preoperative neck ultrasound in clinical node negative differentiated thyroid cancer. J. Clin. Endocrinol. Metab.99(10), 3686–3693 (2014).
   PubMed Web of Science ®Google Scholar
• Kouvaraki M , ShapiroS, FornageBet al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery134(6), 946–954; discussion 954–945 (2003).
   PubMed Web of Science ®Google Scholar
• Moreno MA , AgarwalG, De LunaRet al. Preoperative lateral neck ultrasonography as a long-term outcome predictor in papillary thyroid cancer. Arch. Otolaryngol. Head Neck Surg.137(2), 157–162 (2011).
   PubMedGoogle Scholar
• Lesnik D , CunnaneM, ZurakowskiDet al. Papillary thyroid carcinoma nodal surgery directed by a preoperative radiographic map utilizing CT scan and ultrasound in all primary and reoperative patients. Head Neck36(2), 191–202 (2014).
   PubMed Web of Science ®Google Scholar
• Almeida JP , SanabriaAE, LimaEN, KowalskiLP. Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer. Head Neck33(5), 686–690 (2011).
   PubMed Web of Science ®Google Scholar
• Iyer NG , MorrisLG, TuttleRM, ShahaAR, GanlyI. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Cancer117(19), 4439–4446 (2011).
   PubMed Web of Science ®Google Scholar
• Sawka AM , ThabaneL, ParleaLet al. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid19(5), 451–457 (2009).
   PubMed Web of Science ®Google Scholar
• Tuttle RM , RondeauG, LeeNY. A risk-adapted approach to the use of radioactive iodine and external beam radiation in the treatment of well-differentiated thyroid cancer. Cancer Control18(2), 89–95 (2011).
   PubMed Web of Science ®Google Scholar
• Kruijff S , AnissAM, ChenPet al. Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma. Surgery154(6), 1337–1344; discussion 1344–1335 (2013).
   PubMed Web of Science ®Google Scholar
• Sabra M , GrewalR, GhosseinR, TuttleR. Higher administered activities of radioactive iodine are associated with less structural persistent response in older, but not younger, papillary thyroid cancer patients with lateral neck lymph node metastases. Thyroid21, 21 (2014).
   Google Scholar
• Tuttle RM , TalaH, ShahJet al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid20(12), 1341–1349 (2010).
   PubMed Web of Science ®Google Scholar
• Tuttle RM , FaginJA. Can risk-adapted treatment recommendations replace the ‘one size fits all’ approach for early-stage thyroid cancer patients?Oncology (Williston Park)23(7), 592, 600–603 (2009).
   PubMed Web of Science ®Google Scholar
• Durante C , CostanteG, FilettiS. Differentiated thyroid carcinoma: defining new paradigms for postoperative management. Endocr. Relat. Cancer20(4), R141–R154 (2013).
   PubMed Web of Science ®Google Scholar
• Wang LY , RomanBR, MigliacciJCet al. Cost–effectiveness analysis of papillary thyroid cancer surveillance. Cancer121(23), 4132–4140 (2015).
   PubMed Web of Science ®Google Scholar
• Momesso DP , TuttleRM. Update on differentiated thyroid cancer staging. Endocrinol. Metab. Clin. North Am.43(2), 401–421 (2014).
   PubMed Web of Science ®Google Scholar
• Tuttle R , LeboeufR. Follow up approaches in thyroid cancer: a risk adapted paradigm. Endocrinol. Metab. Clin. North Am.37(2), 419–435 (2008).
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network . Integrated genomic characterization of papillary thyroid carcinoma. Cell159(3), 676–690 (2014).
   PubMed Web of Science ®Google Scholar
• Brose MS , NuttingCM, JarzabBet al. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, Phase 3 trial. Lancet384(9940), 319–328 (2014).
   PubMed Web of Science ®Google Scholar